Vimarsana
Biggest News Aggregation in the World

Page 5 - Primary Scale News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Primary Scale. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Primary Scale Today - Breaking & Trending Today

Air Cleaner to Reduce the Negative Impacts of Air Pollution - Vimarsana News

Air Cleaner to Reduce the Negative Impacts of Air Pollution

According to a recent study, having a portable air cleaner at home can lessen the detrimental effects of air pollution on children’s brain development.

Using air filters at home can reduce negative impacts of air pollution on children's brain development - Vimarsana News

Using air filters at home can reduce negative impacts of air pollution on children's brain development

A new study finds that having a portable air cleaner in the home can reduce the negative impacts of air pollution on brain development in children.

Study reveals reducing air pollution helps build strong brain development in children - Vimarsana News

Study reveals reducing air pollution helps build strong brain development in children

Having a portable air cleaner at home can help in reducing the impact of air pollution on children's brain development, according to a recent study.

Reducing air pollution can support healthy brain development: Study - SFU News - Vimarsana News

Reducing air pollution can support healthy brain development: Study - SFU News

A new study finds that having a portable air cleaner in the home can reduce the negative impacts of air pollution on brain development in children. Simon Fraser University researchers collaborated with U.S. and Mongolian scientists to study the benefits of using air filters to reduce exposure to air pollution during pregnancy, and assessed the impact on children’s intelligence.

Source: sfu.ca
Stoke Therapeutics Presents Data from the Phase 1/2a MONARCH Study of STK-001 in Children and Adolescents with Dravet Syndrome at the American Epilepsy Society (AES) 2021 Annual Meeting - Vimarsana News

Stoke Therapeutics Presents Data from the Phase 1/2a MONARCH Study of STK-001 in Children and Adolescents with Dravet Syndrome at the American Epilepsy Society (AES) 2021 Annual Meeting

– Single doses of STK-001 up to 30mg and multiple doses of 20mg were well tolerated with no safety concerns related to study drug – – 70.6% of patients treated with STK-001... | December 3, 2021